Clinical trial
ELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor Targeting
NCT04241315
Study timeline
Study start (actual)2020-03-26Date precision: day
Registry last updated2023-03-23
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Neoplasmsunresolved
Lung Cancerunresolved
Interventions
Sponsors & collaborators
On Target Laboratories, LLClead sponsor
Clinipace Worldwidecollaborator
Mapped research locations
PittsburghPennsylvania, United States2HoustonTexas, United States1BostonMassachusetts, United States1PhiladelphiaPennsylvania, United States1SeattleWashington, United States1ClevelandOhio, United States1Ann ArborMichigan, United States1RochesterMinnesota, United States1Iowa CityIowa, United States1CharlottesvilleVirginia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04241315 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.